BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22790088)

  • 41. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
    Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
    Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of radiosensitivity in human bladder cell lines using nuclear chromatin phenotype.
    Rajab NF; McKenna DJ; Diamond J; Williamson K; Hamilton PW; McKelvey-Martin VJ
    Cytometry A; 2006 Oct; 69(10):1077-85. PubMed ID: 16924636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
    Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
    Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.
    Herring CJ; Deans B; Elder RH; Rafferty JA; MacKinnon J; Barzilay G; Hickson ID; Hendry JH; Margison GP
    Br J Cancer; 1999 Jun; 80(7):940-5. PubMed ID: 10362100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation.
    Bristow RG; Hu Q; Jang A; Chung S; Peacock J; Benchimol S; Hill R
    Oncogene; 1998 Apr; 16(14):1789-802. PubMed ID: 9583677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.
    Danson S; Ranson M; Denneny O; Cummings J; Ward TH
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
    Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
    Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities.
    Du XL; Jiang T; Wen ZQ; Li QS; Gao R; Wang F
    Oncol Rep; 2009 Mar; 21(3):625-34. PubMed ID: 19212620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiation-induced DNA double-strand breaks produced in histone-depleted tumor cell nuclei measured using the neutral comet assay.
    Olive PL; Banáth JP
    Radiat Res; 1995 May; 142(2):144-52. PubMed ID: 7724728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation-induced DNA damage and repair evaluated with 'comet assay' in human ovarian carcinoma cell lines with different radiosensitivities.
    Bacová G; Hunáková LE; Chorváth M; Boljesíková E; Chorváth B; Sedlák J; Gábelová A
    Neoplasma; 2000; 47(6):367-74. PubMed ID: 11263861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationships between clonogenic cell survival, DNA damage and chromosomal radiosensitivity in nine human cervix carcinoma cell lines.
    Eastham AM; Atkinson J; West CM
    Int J Radiat Biol; 2001 Mar; 77(3):295-302. PubMed ID: 11258843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
    Hedman M; Bergqvist M; Brattström D; Brodin O
    Anticancer Res; 2011 Apr; 31(4):1125-30. PubMed ID: 21508355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivity.
    Moneef MA; Sherwood BT; Bowman KJ; Kockelbergh RC; Symonds RP; Steward WP; Mellon JK; Jones GD
    Br J Cancer; 2003 Dec; 89(12):2271-6. PubMed ID: 14676805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosensitivity and repair kinetics of gamma-irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay.
    Shahidi M; Mozdarani H; Mueller WU
    Iran Biomed J; 2010 Jul; 14(3):67-75. PubMed ID: 21079656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Observation of DNA damage of human hepatoma cells irradiated by heavy ions using comet assay.
    Qiu LM; Li WJ; Pang XY; Gao QX; Feng Y; Zhou LB; Zhang GH
    World J Gastroenterol; 2003 Jul; 9(7):1450-4. PubMed ID: 12854139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.
    Bowman KJ; Al-Moneef MM; Sherwood BT; Colquhoun AJ; Goddard JC; Griffiths TR; Payne D; Singh S; Butterworth PC; Khan MA; Summerton DJ; Steward WP; McKelvey-Martin VJ; McKeown SR; Kockelbergh RC; Mellon JK; Symonds RP; Jones GD
    Int J Cancer; 2014 Mar; 134(5):1102-11. PubMed ID: 23959905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcription profile of DNA damage response genes at G₀ lymphocytes exposed to gamma radiation.
    Saini D; Shelke S; Mani Vannan A; Toprani S; Jain V; Das B; Seshadri M
    Mol Cell Biochem; 2012 May; 364(1-2):271-81. PubMed ID: 22258824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comet assay is not useful to predict normal tissue response after radiochemotherapy in cervical and larynx cancer patients.
    Adamczyk A; Biesaga B; Klimek M; Mucha-Małecka A
    Pol J Pathol; 2018; 69(4):410-421. PubMed ID: 30786692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays.
    Djuzenova CS; Mühl B; Fehn M; Oppitz U; Müller B; Flentje M
    Br J Cancer; 2006 Apr; 94(8):1194-203. PubMed ID: 16538220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.